# Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia

> **NCT07144020** · EARLY_PHASE1 · RECRUITING · sponsor: **Zhejiang University** · enrollment: 50 (estimated)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **BIOLOGICAL:** CD117 CAR T-cells

## Key facts

- **NCT ID:** NCT07144020
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-05
- **Primary completion:** 2028-09-05
- **Final completion:** 2028-09-05
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-08-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07144020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07144020, "Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07144020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*